CCDC144NL-AS1

Across TCGA pan-cancer cohorts, CCDC144NL-AS1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CCDC144NL-AS1 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher CCDC144NL-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CCDC144NL-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUSC, LUAD, and SKCM are the cancer types where CCDC144NL-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.152	0.762	.001	12	view →
LUAD	OS	Median	All	0.258	0.787	.027	6	view →
SKCM	DFS	Median	All	0.267	0.640	.047	3	view →
UCEC	DFS	Median	All	1.000	0.626	.047	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CCDC144NL-AS1–LUSC (OS)

Open the LUSC breakdown →